# Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops

> **NCT06172530** · — · UNKNOWN · sponsor: **Hanlim Pharm. Co., Ltd.** · enrollment: 2000 (estimated)

## Conditions studied

- Dry Eye Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06172530
- **Lead sponsor:** Hanlim Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-08
- **Primary completion:** 2024-05
- **Final completion:** 2024-12
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06172530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06172530, "Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06172530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*